The US tariff exemption covers rare-disease medications, cell and gene therapies, and critical specialized active pharmaceutical ingredients.
Tag: Indian pharma
Indian Pharma Industry Warns Trump’s 200% Generic Tariff Threat Would Imperil American Consumers
Industry representatives stated that massive import duties on generic medicines would drastically increase healthcare costs in the United States.
Indian Pharma Firms Face Export Scrutiny Amid New Global Standardization Norms
Exporters of active pharmaceutical ingredients align quality checks with revised medical regulations in Europe.